Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of SAM-531

Back to Search
Print
Bookmark Trial

NCT00479349

Last updated date
Back to Search
Print
Bookmark Trial
FOR MORE INFORMATION
Study Location
Tokyo, , 170-0003, Japan
See other locations
Contact
1-800-718-1021
[email protected]
Related Links

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

By phone

Pfizer Clinical Trials Contact Center

1-800-718-1021

By email

Contact

ClinicalTri[email protected]

Call Now

Eligibility Criteria
condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Alzheimer Disease
Sex
Male
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
20 + years
Inclusion Criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Men aged 20 to 45 years, inclusive, at screening.

- Elderly men or women aged 65 years and above as of screening.

- Body mass index (BMI) in the range of 17.6 to 26.4 kg/m2 and body weight ≥45 kg.

Exclusion critereia

- Any significant cardiovascular, hepatic, renal, respiratory, gastrointestinal, endocrine, immunologic, dermatologic, hematologic, neurologic, or psychiatric disease.

- Any clinically important deviation from normal limits in physical examination, vital signs, 12-lead ECGs, or clinical laboratory test results. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels should be below the upper limit of normal at screening.

- Tobacco use or consumption of any caffeine-containing products (e.g., coffee, tea, chocolate, or carbonated beverages) or alcoholic beverages within 48 hours before study day 1 until the end of the inpatient confinement period.

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

Call Now

TRY A NEW SEARCH

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Advanced Search

Based on your search, you may also be interested in

Alzheimer DiseaseLipitor as a Treatment for Alzheimer's Disease
NCT00024531
  1. Sun City, Arizona
ALL GENDERS
50 Years+
years
MULTIPLE SITES
Alzheimer DiseaseStudy Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients
NCT00667810
  1. Birmingham, Alabama
  2. Goodyear, Arizona
  3. Phoenix, Arizona
  4. Phoenix, Arizona
  5. Phoenix, Arizona
  6. Phoenix, Arizona
  7. Little Rock, Arkansas
  8. Costa Mesa, California
  9. Encino, California
  10. Fresno, California
  11. Laguna Hills, California
  12. Laguna Hills, California
  13. Loma Linda, California
  14. Loma Linda, California
  15. Long Beach, California
  16. Los Alamitos, California
  17. Newport Beach, California
  18. San Diego, California
  19. San Diego, California
  20. San Diego, California
  21. San Diego, California
  22. San Diego, California
  23. San Diego, California
  24. San Francisco, California
  25. Boulder, Colorado
  26. Boulder, Colorado
  27. Denver, Colorado
  28. Danbury, Connecticut
  29. Fairfield, Connecticut
  30. Greenwich, Connecticut
  31. Greenwich, Connecticut
  32. New Haven, Connecticut
  33. New Haven, Connecticut
  34. New Haven, Connecticut
  35. New Haven, Connecticut
  36. New Haven, Connecticut
  37. New Haven, Connecticut
  38. New Haven, Connecticut
  39. New Haven, Connecticut
  40. Norwalk, Connecticut
  41. Waterbury, Connecticut
  42. Atlantis, Florida
  43. Atlantis, Florida
  44. Bradenton, Florida
  45. Deerfield Beach, Florida
  46. Delray Beach, Florida
  47. Fort Lauderdale, Florida
  48. Hallandale Beach, Florida
  49. Ocala, Florida
  50. Ocala, Florida
  51. Orlando, Florida
  52. Palm Beach Gardens, Florida
  53. Port Charlotte, Florida
  54. Sarasota, Florida
  55. Sun City, Florida
  56. Tampa, Florida
  57. West Palm Beach, Florida
  58. Atlanta, Georgia
  59. Columbus, Georgia
  60. Columbus, Georgia
  61. Decatur, Georgia
  62. Decatur, Georgia
  63. Lawerenceville, Georgia
  64. Lawrenceville, Georgia
  65. Elk Grove Village, Illinois
  66. Elk Grove Village, Illinois
  67. Peoria, Illinois
  68. Peoria, Illinois
  69. Peoria, Illinois
  70. Peoria, Illinois
  71. Springfield, Illinois
  72. Springfield, Illinois
  73. Elkhart, Indiana
  74. Mishawaka, Indiana
  75. Wichita, Kansas
  76. Wichitia, Kansas
  77. Paducah, Kentucky
  78. Paducah, Kentucky
  79. Lake Charles, Louisiana
  80. New Orleans, Louisiana
  81. Shreveport, Louisiana
  82. Bethesda, Maryland
  83. Rockville, Maryland
  84. Boston, Massachusetts
  85. Boston, Massachusetts
  86. Boston, Massachusetts
  87. Boston, Massachusetts
  88. Boston, Massachusetts
  89. Boston, Massachusetts
  90. Boston, Massachusetts
  91. Haverhill, Massachusetts
  92. Newton, Massachusetts
  93. Springfield, Massachusetts
  94. Ann Arbor, Michigan
  95. Ann Arbor, Michigan
  96. Ann Arbor, Michigan
  97. East Lansing, Michigan
  98. Lansing, Michigan
  99. Flowood, Mississippi
  100. Flowood, Mississippi
  101. Hattiesburg, Mississippi
  102. Kansas City, Missouri
  103. Great Falls, Montana
  104. Great Falls, Montana
  105. Berlin, New Jersey
  106. Eatontown, New Jersey
  107. Manchester, New Jersey
  108. Toms River, New Jersey
  109. Brewster, New York
  110. Liverpool, New York
  111. Rochester, New York
  112. Rochester, New York
  113. Asheville, North Carolina
  114. Charlotte, North Carolina
  115. Hickory, North Carolina
  116. Hickory, North Carolina
  117. Raleigh, North Carolina
  118. Raleigh, North Carolina
  119. Raleigh, North Carolina
  120. Raleigh, North Carolina
  121. Columbus, Ohio
  122. Columbus, Ohio
  123. Columbus, Ohio
  124. Columbus, Ohio
  125. Toledo, Ohio
  126. Oklahoma City, Oklahoma
  127. Oklahoma City, Oklahoma
  128. Oklahoma City, Oklahoma
  129. Portland, Oregon
  130. Abington, Pennsylvania
  131. Abington, Pennsylvania
  132. Jenkintown, Pennsylvania
  133. Philadelphia, Pennsylvania
  134. Philadelphia, Pennsylvania
  135. Philadelphia, Pennsylvania
  136. Philadelphia, Pennsylvania
  137. Philadelphia, Pennsylvania
  138. Philadelphia, Pennsylvania
  139. Pittsburgh, Pennsylvania
  140. Willow Grove, Pennsylvania
  141. East Providence, Rhode Island
  142. Pawtucket, Rhode Island
  143. Providence, Rhode Island
  144. Charleston, South Carolina
  145. Charleston, South Carolina
  146. Greer, South Carolina
  147. North Charleston, South Carolina
  148. Cordova, Tennessee
  149. Austin, Texas
  150. Austin, Texas
  151. Dallas, Texas
  152. Fort Worth, Texas
  153. San Antonio, Texas
  154. San Antonio, Texas
  155. San Antonio, Texas
  156. San Antonio, Texas
  157. Wichita Falls, Texas
  158. Bennington, Vermont
  159. Bennington, Vermont
  160. Charlottesville, Virginia
  161. Charlottesville, Virginia
  162. Charlottesville, Virginia
  163. Bothell, Washington
  164. Seattle, Washington
  165. Buenos Aires,
  166. Buenos Aires,
  167. Gosford, New South Wales
  168. Hornsby, New South Wales
  169. Woodville South, South Australia
  170. Ballarat, Victoria
  171. West Heidelberg, Victoria
  172. Nedlands, Western Australia
  173. Nedlands, Western Australia
  174. Adelaide SA,
  175. Antwerpen,
  176. Brugge,
  177. Bruxelles,
  178. Edegem,
  179. Leuven,
  180. Roeselare,
  181. North York, Ontario
  182. Ottawa, Ontario
  183. Toronto, Ontario
  184. Toronto, Ontario
  185. L'Ancienne-Lorette, Quebec
  186. Montreal, Quebec
  187. Montreal, Quebec
  188. Sherbrooke, Quebec
  189. Quebec,
  190. Santiago,
  191. Santiago,
  192. Zagreb,
  193. Zagreb,
  194. Kuopio,
  195. Turku,
  196. Rennes, Cedex
  197. Amiens,
  198. Bron,
  199. Caen,
  200. Colmar,
  201. Dijon,
  202. Lille,
  203. Marseille,
  204. Marseille,
  205. Montpellier,
  206. Nantes - Saint Herblain,
  207. Nice,
  208. Paris Cedex 13,
  209. Paris,
  210. Poitiers,
  211. Reims,
  212. Rouen,
  213. Toulouse,
  214. Toulouse,
  215. Berlin,
  216. Bochum,
  217. Offenburg,
  218. Regensburg,
  219. Ancona,
  220. Brescia,
  221. Catania,
  222. Chieti,
  223. Firenze,
  224. Milano,
  225. Milano,
  226. Milano,
  227. Monza,
  228. Monza,
  229. Roma,
  230. Roma,
  231. Siena,
  232. Nagoya, Aichi,
  233. Ota-ku, Tokyo
  234. Aichi,
  235. Chiba,
  236. Chiba,
  237. Chiba,
  238. Fukuoka,
  239. Gunma,
  240. Gunma,
  241. Gunma,
  242. Hiroshima,
  243. Hyogo,
  244. Hyogo,
  245. Hyogo,
  246. Iwate,
  247. Kagawa,
  248. Kanagawa,
  249. Kanagawa,
  250. Kanagawa,
  251. Kyoto,
  252. Kyoto,
  253. Kyoto,
  254. Nagano,
  255. Niigata,
  256. Okayama,
  257. Okayama,
  258. Osaka,
  259. Osaka,
  260. Osaka,
  261. Shizuoka,
  262. Tokyo,
  263. Tokyo,
  264. Tokyo,
  265. Tokyo,
  266. Tokyo,
  267. Seongnam-si, Gyeonggi-do
  268. Seoul,
  269. Monterrey, Nuevo León
  270. Aguascalientes,
  271. 's-Hertogenbosch,
  272. Amsterdam,
  273. Breda,
  274. Eindhoven,
  275. Haarlem,
  276. Leeuwarden,
  277. s. Hertogenbosch,
  278. Auckland, NZ
  279. Christchurch,
  280. Bydgoszcz,
  281. Kielce,
  282. Krakow,
  283. Poznan,
  284. Warszawa,
  285. Warszawa,
  286. Amadora,
  287. Coimbra,
  288. Lisboa,
  289. Kazan,
  290. Nizhny Novgorod,
  291. Saint-Petersburg,
  292. Saint-Petersburg,
  293. Saint-Petersburg,
  294. Saint-Petersburg,
  295. Novi Sad, Vojvodina
  296. Belgrade,
  297. Beograd,
  298. Kragujevac,
  299. Bratislava,
  300. Bratislava,
  301. Bratislava,
  302. Bratislava,
  303. Martin,
  304. Michalovce,
  305. Rimavska Sobota,
  306. Zilina,
  307. Johannesburg, Gauteng
  308. Johannesburg, Gauteng
  309. Pretoria, Gauteng
  310. Durban, Kwa Zulu Natal
  311. Panorama, Western Cape
  312. Elche, Alicante
  313. Terrassa, Barcelona
  314. Plasencia, Caceres
  315. Palma de Mallorca, Islas Baleares
  316. Palma de Mallorca, Islas Baleares
  317. Baracaldo,
  318. Barcelona,
  319. Barcelona,
  320. Barcelona,
  321. Barcelona,
  322. Burgos,
  323. Madrid,
  324. Madrid,
  325. Madrid,
  326. Madrid,
  327. Madrid,
  328. Murcia,
  329. Malmo,
  330. Uppsala,
  331. Uppsala,
  332. Uppsala,
  333. Basel, BS
  334. Les Acacias, GE
  335. Lausanne, VD
  336. Thonex-Geneva,
  337. Blackpool, Lancashire
  338. Bradford, West Yorkshire
  339. Brighton,
  340. Glasgow,
  341. London,
  342. London,
  343. Newcastle upon Tyne,
  344. Northampton,
  345. Penarth,
  346. Sheffield,
  347. Sheffield,
  348. Swindon,
ALL GENDERS
50 Years+
years
MULTIPLE SITES
Alzheimer DiseaseStudy Evaluating PAZ-417 in Cerebrospinal Fluid in Subjects With Alzheimer's Disease
NCT00739037
  1. Glendale, California
ALL GENDERS
55 Years+
years
MULTIPLE SITES
Alzheimer DiseaseStudy Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients
NCT00676143
  1. Birmingham, Alabama
  2. Birmingham, Alabama
  3. Birmingham, Alabama
  4. Birmingham, Alabama
  5. Goodyear, Arizona
  6. Phoenix, Arizona
  7. Phoenix, Arizona
  8. Phoenix, Arizona
  9. Phoenix, Arizona
  10. Little Rock, Arkansas
  11. Carson, California
  12. Long Beach, California
  13. San Francisco, California
  14. Boulder, Colorado
  15. Boulder, Colorado
  16. Denver, Colorado
  17. Fairfield, Connecticut
  18. Greenwich, Connecticut
  19. Greenwich, Connecticut
  20. New Haven, Connecticut
  21. New Haven, Connecticut
  22. New Haven, Connecticut
  23. New Haven, Connecticut
  24. New Haven, Connecticut
  25. New Haven, Connecticut
  26. New Haven, Connecticut
  27. Norwalk, Connecticut
  28. Atlantis, Florida
  29. Atlantis, Florida
  30. Atlantis, Florida
  31. Delray Beach, Florida
  32. Orlando, Florida
  33. Palm Beach Gardens, Florida
  34. Port Charlotte, Florida
  35. Sarasota, Florida
  36. Tampa, Florida
  37. Decatur, Georgia
  38. Decatur, Georgia
  39. Lawrenceville, Georgia
  40. Elk Grove Village, Illinois
  41. Springfield, Illinois
  42. Springfield, Illinois
  43. Kansas City, Kansas
  44. Lake Charles, Louisiana
  45. Boston, Massachusetts
  46. Boston, Massachusetts
  47. Boston, Massachusetts
  48. Boston, Massachusetts
  49. Boston, Massachusetts
  50. Boston, Massachusetts
  51. Boston, Massachusetts
  52. Dartmouth, Massachusetts
  53. Pittsfield, Massachusetts
  54. Springfield, Massachusetts
  55. Ann Arbor,, Michigan
  56. Ann Arbor, Michigan
  57. Ann Arbor, Michigan
  58. Ann Arbor, Michigan
  59. East Lansing, Michigan
  60. Hattiesburg, Mississippi
  61. Kansas City, Missouri
  62. Eatontown, New Jersey
  63. Edison, New Jersey
  64. Manchester, New Jersey
  65. Liverpool, New York
  66. Raleigh, North Carolina
  67. Raleigh, North Carolina
  68. Raleigh, North Carolina
  69. Raleigh, North Carolina
  70. Columbs, Ohio
  71. Columbs, Ohio
  72. Columbus, Ohio
  73. Portland, Oregon
  74. Portland, Oregon
  75. Portland, Oregon
  76. Portland, Oregon
  77. Silverton, Oregon
  78. Abington, Pennsylvania
  79. Abington, Pennsylvania
  80. Abington, Pennsylvania
  81. Flourtown, Pennsylvania
  82. Jenkintown, Pennsylvania
  83. Philadelphia, Pennsylvania
  84. Philadelphia, Pennsylvania
  85. Philadelphia, Pennsylvania
  86. Philadelphia, Pennsylvania
  87. Philadelphia, Pennsylvania
  88. Philadelphia, Pennsylvania
  89. Willow Grove, Pennsylvania
  90. East Providence, Rhode Island
  91. Pawtucket, Rhode Island
  92. Providence, Rhode Island
  93. Charleston, South Carolina
  94. Charleston, South Carolina
  95. Charleston, South Carolina
  96. North Charleston, South Carolina
  97. Dallas, Texas
  98. San Antonio, Texas
  99. San Antonio, Texas
  100. San Antonio, Texas
  101. San Antonio, Texas
  102. San Antonio, Texas
  103. San Antonio, Texas
  104. San Antonio, Texas
  105. Bennington, Vermont
  106. Bennington, Vermont
  107. Madison, Wisconsin
  108. Madison, Wisconsin
  109. Madison, Wisconsin
  110. Madison, Wisconsin
  111. Madison, Wisconsin
  112. Buenos Aires,
  113. Buenos Aires,
  114. Buenos Aires,
  115. Cordoba,
  116. Gosford, New South Wales
  117. Gosford, New South Wales
  118. Hornsby, New South Wales
  119. Adelaide, South Australia
  120. Woodville South, South Australia
  121. Ballarat, Victoria
  122. West Heidelberg, Victoria
  123. Nedlands, Western Australia
  124. Nedlands, Western Australia
  125. Graz,
  126. Klagenfurt,
  127. Wien,
  128. Wien,
  129. Wien,
  130. Antwerpen,
  131. Brugge,
  132. Brussels,
  133. Edegem,
  134. Leuven,
  135. Roeselare,
  136. Santiago,
  137. Santiago,
  138. Zagreb,
  139. Kuopio,
  140. Turku,
  141. Bordeaux Cedex,
  142. Bron,
  143. Caen,
  144. Caen,
  145. Colmar,
  146. Dijon,
  147. Lille,
  148. Marseille,
  149. Montpellier,
  150. Nantes - Saint Herblain,
  151. Nice,
  152. Nice,
  153. Paris,
  154. Paris,
  155. Poitiers,
  156. Reims,
  157. Rennes Cedex,
  158. Rouen,
  159. Toulouse,
  160. Toulouse,
  161. Berlin,
  162. Bochum,
  163. Dresden,
  164. Freiburg,
  165. Offenburg,
  166. Ulm,
  167. Ancona,
  168. Ancona,
  169. Brescia,
  170. Catania,
  171. Catania,
  172. Chieti,
  173. Milano,
  174. Monza,
  175. Roma,
  176. Roma,
  177. Siena,
  178. Nagoya, Aichi,
  179. Kiyose, Tokyo
  180. Aichi,
  181. Chiba,
  182. Chiba,
  183. Chiba,
  184. Fukuoka,
  185. Gunma,
  186. Gunma,
  187. Gunma,
  188. Hiroshima,
  189. Hyogo,
  190. Hyogo,
  191. Hyogo,
  192. Iwate,
  193. Kagawa,
  194. Kanagawa,
  195. Kanagawa,
  196. Kanagawa,
  197. Kyoto,
  198. Kyoto,
  199. Kyoto,
  200. Nagano,
  201. Niigata,
  202. Okayama,
  203. Okayama,
  204. Osaka,
  205. Osaka,
  206. Osaka,
  207. Shizuoka,
  208. Tokyo,
  209. Tokyo,
  210. Tokyo,
  211. Tokyo,
  212. Tokyo,
  213. Monterrey, Nuevo León
  214. Aguascalientes,
  215. Breda, Noord Brabant
  216. Hilversum, Noord Holland
  217. Haarlem, The Netherlands
  218. 's-Hertogenbosch,
  219. Alkmaar,
  220. Amsterdam,
  221. Eindhoven,
  222. Leeuwarden,
  223. Rotterdam,
  224. Auckland, NZ
  225. Christchurch,
  226. Bydgoszcz,
  227. Krakow,
  228. Poznan,
  229. Warszawa,
  230. Warszawa,
  231. Amadora,
  232. Coimbra,
  233. Lisboa,
  234. Belgrade,
  235. Kragujevac,
  236. Novi Sad,
  237. Sremska Kamenica,
  238. Sremska Kamenica,
  239. Bratislava,
  240. Bratislava,
  241. Michalovce,
  242. Rimavska Sobota,
  243. Johannesburg, Gauteng
  244. Johannesburg, Gauteng
  245. Pretoria, Gauteng
  246. Durban, Kwa Zulu Natal
  247. Bellville, Western Cape
  248. Panorama, Western Cape
  249. Elche, Alicante
  250. Terrassa, Barcelona
  251. Plasencia, Caceres
  252. Palma de Mallorca, Islas Baleares
  253. Palma de Mallorca, Islas Baleares
  254. San Sebastian, Pais Vasco
  255. Baracaldo, Vizcalla
  256. Barcelona,
  257. Barcelona,
  258. Barcelona,
  259. Barcelona,
  260. Burgos,
  261. Madrid,
  262. Madrid,
  263. Madrid,
  264. Madrid,
  265. Madrid,
  266. Murcia,
  267. Malmo,
  268. Uppsala,
  269. Uppsala,
  270. Uppsala,
  271. Basel, BS
  272. Les Acacias, GE
  273. Lausanne, VD
  274. Thonex-Geneva,
  275. Blackpool, Lancashire
  276. Trafford Park, Manchester
  277. Bradford,
  278. Brighton,
  279. Glasgow,
  280. London,
  281. London,
  282. Newcastle upon Tyne,
  283. Northampton,
  284. Penarth,
  285. Sheffield,
  286. Sheffield,
  287. Swindon,
ALL GENDERS
50 Years+
years
MULTIPLE SITES
Advanced Information
Descriptive Information
Brief Title  ICMJE Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of SAM-531
Official Title  ICMJE An Ascending Multiple Dose Study of the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of SAM-531 Administered Orally to Healthy Japanese Young Male and Elderly Subjects
Brief Summary To assess the safety and tolerability of ascending multiple oral doses of SAM-531, an investigational drug, in healthy Japanese young male and elderly subjects.To provide the pharmacokinetics (PK) and pharmacodynamics (PD) profiles of multiple oral doses of SAM-531 in healthy Japanese young male and elderly subjects.
Detailed Description Not Provided
Study Type  ICMJE Interventional
Study Phase  ICMJE Phase 1
Study Design  ICMJE Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Condition  ICMJE Alzheimer Disease
Intervention  ICMJE Drug: SAM-531
Multiple ascending doses of SAM 531: 1,5; 3 and 5 mg.
Study Arms  ICMJE Active Comparator: 1
SAM 531 + placebo
Intervention: Drug: SAM-531
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Completed
Estimated Enrollment  ICMJE
 (submitted: May 24, 2007)		32
Original Enrollment  ICMJE Same as current
Actual Study Completion Date  ICMJE January 2008
Actual Primary Completion Date January 2008   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion criteria

  • Men aged 20 to 45 years, inclusive, at screening.
  • Elderly men or women aged 65 years and above as of screening.
  • Body mass index (BMI) in the range of 17.6 to 26.4 kg/m2 and body weight ?45 kg.

Exclusion critereia

  • Any significant cardiovascular, hepatic, renal, respiratory, gastrointestinal, endocrine, immunologic, dermatologic, hematologic, neurologic, or psychiatric disease.
  • Any clinically important deviation from normal limits in physical examination, vital signs, 12-lead ECGs, or clinical laboratory test results. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels should be below the upper limit of normal at screening.
  • Tobacco use or consumption of any caffeine-containing products (e.g., coffee, tea, chocolate, or carbonated beverages) or alcoholic beverages within 48 hours before study day 1 until the end of the inpatient confinement period.
Sex/Gender  ICMJE
Sexes Eligible for Study:Male
Ages  ICMJE 20 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers  ICMJE Yes
Contacts  ICMJE Contact information is only displayed when the study is recruiting subjects
Listed Location Countries  ICMJE Japan
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT00479349
Other Study ID Numbers  ICMJE 3193A1-1104
Has Data Monitoring Committee Not Provided
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement  ICMJE Not Provided
Responsible Party Wyeth (Registry Contact: Clinical Trial Registry Specialist), Wyeth
Study Sponsor  ICMJE Wyeth is now a wholly owned subsidiary of Pfizer
Collaborators  ICMJE Not Provided
Investigators  ICMJE
Study Director:Medical MonitorWyeth is now a wholly owned subsidiary of Pfizer
PRS Account Wyeth is now a wholly owned subsidiary of Pfizer
Verification Date July 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP